A new study published in the Journal of Periodontology showed that periodontitis severity and total prostate-specific antigen ...

A leading doctor has answered several common questions about prostate cancer in an effort to separate facts from fiction. His ...

Dr Thornton stressed that ignoring symptoms and postponing doctor visits are among the worst strategies for dealing with ...

A prominent doctor has tackled several frequently asked questions regarding prostate cancer in a bid to distinguish fact from ...

Coversure Insurance Brokers has launched a network-wide prostate cancer screening initiative, funding free prostate-specific ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec. 23, ...

Investigators compared PSA90 response between new users of apalutamide vs abiraterone for mCSPC using a large US cohort.

MELBOURNE, Australia and INDIANAPOLIS, /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix') today ...

I was one in eight. One in eight men will be diagnosed with prostate cancer in their lifetime. Nah, I was one in six. One in ...

A community health initiative offering 300 free prostate‑specific antigen (PSA) screenings to the public has been launched.